Eagle Asset Management Inc Intercept Pharmaceuticals, Inc. Transaction History

Eagle Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $10.5 Million - $14.4 Million	-269,427 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$46.7 - $92.04 $12.6 Million - $24.8 Million	269,427 New	269,427 $12.6 Million
Q1 2019 May 01, 2019	SELL	$91.83 - $120.68 $26.2 Million - $34.5 Million	-285,666 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$85.79 - $126.46 $24.5 Million - $36.1 Million	285,666 New	285,666 $28.8 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.